Johnson & Johnson (NY:JNJ)

They have both outperformed the broader equity market over the long run.

Topics Economy

2 Growth Stocks to Buy in November Without Any Hesitation ↗

November 05, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ

November 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗

October 20, 2026

Via Chartmill

Topics Stocks

Worried About an AI Bubble? This ETF Could Be the Smartest Buy Right Now ↗

November 03, 2026

This ETF offers a smart middle ground for investors anxious about the AI trade but who don't want to sit on the sidelines.

AbbVie, J&J, and Medtronic remain reliable dividend plays in a rough market.

Topics Artificial Intelligence ETFs

The Best Dividend Stocks to Buy With $5,000 in November ↗

November 02, 2026

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing. ↗

Topics Artificial Intelligence Economy

November 01, 2026

Selling surgical robots is not the largest source of Intuitive Surgical's revenue.

Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results

November 01, 2026

Medtronic grew revenue by 14% in the first quarter of its fiscal 2027.

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? ↗

November 01, 2026

Consumers don't stop buying vital products during bear markets, which is why healthcare and consumer staples stocks are smart investments.

If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to Own ↗

October 31, 2026

Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors. ↗

October 30, 2026

Johnson & Johnson's third-quarter 2026 earnings look terrible, until you dig into the story a little bit more.

Warren Buffett Says Most Investors Should Buy the S&P 500. Here's How Much You Can Actually Earn With This ETF. ↗

Topics Lawsuit

October 30, 2026

Instead of trying to pick stocks like Warren Buffett, follow his advice and buy this S&P 500 ETF.

With just two days to go, these Dividend Kings with attractive yields could be just what you are looking for in October.

Topics ETFs Economy Stocks

3 Unstoppable S&P 500 Stocks to Buy Before October Ends ↗

October 29, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ

Topics Economy Stocks

October 27, 2026

From Pomerantz LLP

Via GlobeNewswire

Johnson & Johnson to Host Enterprise Business Review

October 27, 2026

Teradyne, Grail, Kratos Defense, FormFactor and Fabrinet have pulled back despite strong growth, setting up potential entry points in robotics, quantum and AI.

5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps ↗

October 26, 2026

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

Topics Artificial Intelligence

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? ↗

October 24, 2026

Intuitive Surgical posted Q3 margin impairments from a legal settlement and pricing changes, but revenue grew 21.5%, guidance firmed, and analysts and institutions remain bullish on ISRG.

Dow Jones Top Movers Today: PG and JNJ Lead Gainers, CAT and AMZN Lead Losers ↗

October 22, 2026

Via Chartmill

Topics Stocks

Dow Jones Top Movers: Gainers and Losers on October 22, 2026 ↗

October 22, 2026

Via Chartmill

Topics Stocks

Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story ↗

October 22, 2026

Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026

Topics Lawsuit

October 22, 2026

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 ↗

October 21, 2026

The market has rewarded this biotech for its breakthroughs.

These drugmakers are facing some near-term challenges, but is that enough to stop their recent momentum?

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) ↗

October 20, 2026

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

October 20, 2026

Polls suggest a divided government after the midterms, a scenario that historically benefits healthcare stocks. Here's how the XLV and IHF ETFs compare for investors eyeing the sector.

What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs ↗

October 19, 2026

JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS Law

Topics ETFs

October 17, 2026

From Schall, Brown & Schwartz LLP

Looking beyond near-term headwinds paints a fairly bright picture of Johnson & Johnson’s outlook.

Should You Invest in This Dividend King on the Dip? ↗

October 17, 2026

When the Stock Market Gets Dangerous, These 6 Investments Have a History of Holding Up ↗

October 17, 2026

These companies generate resilient revenues, which help make their stocks less volatile during market downturns.

Tech stocks fell on inflation fears and AI infrastructure concerns while the Dow rose, as MarketBeat analysts review earnings outlooks, sector rotation, and stock picks from the week's top stories.

Topics Economy

MarketBeat Week in Review – 10/12 - 10/16 ↗

October 17, 2026

Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. ↗

Topics Artificial Intelligence Economy Stocks

October 17, 2026

The guidance bump doesn't matter nearly as much as investors' response to the company's Q3 report suggests.